Get the full picture
Sign in to uncover key details.
Sentrimed
Manufacturing · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
107 Gilbreth Pkwy, Mullica Hill, New Jer...Phone Number
(856) 651-7140Website
www.sentrimed.comRevenue
<$5 MillionIndustry
About Sentrimed
Sentrimed is a clinical-stage biopharmaceutical company focused on developing safer, oral oncology therapies that target podoplanin (PDPN), a key cancer biomarker. Their lead asset, MASL (lenipagrusin alfa), is aimed at treating Head and Neck Cancer, with potential applications for other cancers as well. The company has completed an NIH-funded human signal trial demonstrating the safety and efficacy of their treatment. Sentrimed's innovative approach seeks to improve clinical outcomes for cancer patients by inhibiting tumor cell proliferation and migration.Explore more
Sentrimed Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Sentrimed
Compare insights from companies similar to Sentrimed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Sentrimed Tech Stack
A closer look at the technologies used by Sentrimed
Top Manufacturing Companies
Frequently Asked Questions Regarding Sentrimed
Sign Up For FreeTo access detailed company insights
Sentrimed is a clinical-stage biopharmaceutical company focused on developing safer, oral oncology therapies that target podoplanin (PDPN), a key cancer biomarker. Their lead asset, MASL (lenipagrusin alfa), is aimed at treating Head and Neck Cancer, with potential applications for other cancers as well. The company has completed an NIH-funded huma... Read More
